These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37017917)

  • 1. Advantages of Material Biofunctionalization Using Nucleic Acid Aptamers in Tissue Engineering and Regenerative Medicine.
    Abpeikar Z; Alizadeh AA; Rezakhani L; Ramezani V; Goodarzi A; Safaei M
    Mol Biotechnol; 2023 Dec; 65(12):1935-1953. PubMed ID: 37017917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicine.
    Koerselman M; Morshuis LCM; Karperien M
    Acta Biomater; 2023 Oct; 170():1-14. PubMed ID: 37517622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-functionalized hydrogels: An emerging class of biomaterials for protein delivery, cell capture, regenerative medicine, and molecular biosensing.
    Abune L; Davis B; Wang Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1731. PubMed ID: 34132055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-Functionalized Bioscaffold Enhances Cartilage Repair by Improving Stem Cell Recruitment in Osteochondral Defects of Rabbit Knees.
    Wang X; Song X; Li T; Chen J; Cheng G; Yang L; Chen C
    Am J Sports Med; 2019 Aug; 47(10):2316-2326. PubMed ID: 31233332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer Technology and Its Applications in Bone Diseases.
    Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
    Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of fabrication technologies and materials for bone tissue engineering.
    Wubneh A; Tsekoura EK; Ayranci C; Uludağ H
    Acta Biomater; 2018 Oct; 80():1-30. PubMed ID: 30248515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide-functionalized hydrogels for sustained release of small molecule (aptamer) therapeutics.
    Agrawal NK; Allen P; Song YH; Wachs RA; Du Y; Ellington AD; Schmidt CE
    Acta Biomater; 2020 Jan; 102():315-325. PubMed ID: 31760222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-Functionalized Hybrid Nanostructures for Sensing, Drug Delivery, Catalysis and Mechanical Applications.
    Vázquez-González M; Willner I
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids.
    Meek KN; Rangel AE; Heemstra JM
    Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in Aptamer-Based Functional Probes for Bioanalysis and Biomedicine.
    Zhang H; Zhou L; Zhu Z; Yang C
    Chemistry; 2016 Jul; 22(29):9886-900. PubMed ID: 27243551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress of SELEX methods for screening nucleic acid aptamers.
    Zhu C; Feng Z; Qin H; Chen L; Yan M; Li L; Qu F
    Talanta; 2024 Jan; 266(Pt 1):124998. PubMed ID: 37527564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A basic insight into aptamer-drug conjugates (ApDCs).
    Xuan W; Peng Y; Deng Z; Peng T; Kuai H; Li Y; He J; Jin C; Liu Y; Wang R; Tan W
    Biomaterials; 2018 Nov; 182():216-226. PubMed ID: 30138784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid-based aptamers: applications, development and clinical trials.
    Kanwar JR; Roy K; Maremanda NG; Subramanian K; Veedu RN; Bawa R; Kanwar RK
    Curr Med Chem; 2015; 22(21):2539-57. PubMed ID: 25723512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid aptamer-based methods for diagnosis of infections.
    Park KS
    Biosens Bioelectron; 2018 Apr; 102():179-188. PubMed ID: 29136589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid aptamers: an emerging frontier in cancer therapy.
    Zhu G; Ye M; Donovan MJ; Song E; Zhao Z; Tan W
    Chem Commun (Camb); 2012 Nov; 48(85):10472-80. PubMed ID: 22951893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence in Aptamer-Target Binding Prediction.
    Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of aptamer internalization mechanisms and their applications in drug delivery.
    Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF
    Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging cancer targets for aptamer delivery.
    de Franciscis V
    Biochimie; 2018 Feb; 145():45-52. PubMed ID: 28962871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.